Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.Read more

The World Health Organization has raised the risk of the Bundibugyo strain of Ebola turning into a national outbreak in the Democratic Republic of Congo to “very high”.

The ⁠strain, for which there is no approved vaccine or treatment, was declared an emergency of international concern by the WHO on Sunday.

“We are now revising our risk assessment to very high at the national level, ⁠high at the regional level, ​and ⁠low at global level,” WHO Chief Tedros Adhanom Ghebreyesus told reporters.

So far, 82 cases have been confirmed in ⁠Congo, with seven confirmed deaths, 177 suspected deaths and almost ​750 ⁠suspected cases. The situation in Uganda ‌is stable, with two cases confirmed in people who travelled from the DRC, one of them fatal, Tedros said.

“The potential of ‌this virus spreading rapidly is high, ‌very high, and that changed the whole dynamic,” said Abdirahman Mahamud, WHO Director of Health Emergency Alert & Response Operations.

Measures taken in Uganda, including intense contact tracing and ⁠cancellation of a mass gathering, appear to have been effective in stemming the spread of the virus, Tedros said.

A U.S. national who was working in Congo has been confirmed positive and transferred to Germany for care.

“We are also aware of reports today about another American national with a high-risk contact who has ‌been transferred to the Czech Republic,” Tedros added.

The WHO’s ​chief scientist, Sylvie Briand, said an antiviral treatment called ‌Obeldesivir could be used among ⁠Ebola contacts to prevent them developing the disease.

Obeldesivir is ⁠an experimental oral COVID antiviral drug from Gilead Sciences.

“This is a promising treatment ‌drug, but it ​has still to be implemented under ‌a very, very strict protocol,” ​Briand said.

Britain will provide up to £20 million to contain the outbreak of Ebola in the eastern Democratic Republic of the Congo and Uganda, it announced today.

The money, provided by the Foreign, Commonwealth and Development Office, will help the international effort to contain the virus through support for frontline health workers, improved infection control and disease surveillance.